Entrada Therapeutics Inc
TRDA10.630USD
+0.010+0.09%
Close 12/23, 16:00（ET）Quotes delayed by 15 min
406.27MMarket Cap
LossP/E TTM
Entrada Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
210.78M
63.38%
EPS(YoY)
1.76
969.68%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its total revenue reached 210.78M, with a year-on-year change of 63.38%.
What is the Earnings Per Share (EPS) of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 1.759, with a year-on-year change of 969.68%.
What is the net income of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its net income was 65.63M, with a year-on-year change of 1081.69%.
What is the net margin of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its net profit margin was 31.13%, with a year-on-year change of 700.86%.
What is the gross margin of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was 19.56%, with a year-on-year change of 765.51%.
What is the Return on Assets (ROA) of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 13.18%, with a year-on-year change of 811.23%.
What is the operating profit of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its operating profit was 47.01M, with a year-on-year change of 1586.75%.
What are the current assets of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its current assets were 440.04M, with a year-on-year change of 19.00%.
What are the total assets of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its total assets of Entrada Therapeutics Inc were 526.32M, with a year-on-year change of 12.18%.
What are the total liabilities of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its total liabilities of Entrada Therapeutics Inc were 97.64M, with a year-on-year change of -56.95%.
What is the total equity of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its total equity of Entrada Therapeutics Inc was 428.68M, with a year-on-year change of 76.88%.
What is the net operating income of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its net operating income of Entrada Therapeutics Inc was 65.63M, with a year-on-year change of 1081.69%.
What is the net investment of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its net investment of Entrada Therapeutics Inc was -27.80M, with a year-on-year change of 79.91%.
What is the net financing of Entrada Therapeutics Inc?
According to Entrada Therapeutics Inc's FY2024 earnings report, its net financing of Entrada Therapeutics Inc was 102.96M, with a year-on-year change of 389.44%.
